Table 4.
Vaccination barriers and attitudes of the parents of foreign-born and U.S.-born adolescents for HPV a, Tdap a and MenACWY a vaccines – National Immunization Survey-Teen, 2012–2013.
| Attitudes supporting HPV vaccination | Foreign-born |
U.S.-born |
||
|---|---|---|---|---|
| % | 95% CIb | % | 95% CIb | |
| Prevents HPV infection* | 77.9 | (73.8, 82.0) | 69.6 | (68.6, 70.5) |
| Prevents cervical cancer* | 75.7 | (71.4, 79.9) | 66.1 | (65.1, 67.1) |
| It is safe* | 69.7 | (64.8, 74.5) | 62.9 | (61.9, 63.9) |
| Prevents genital warts* | 63.6 | (58.6, 68.5) | 48.8 | (47.7, 49.8) |
| Prevents anal cancer* | 46.7 | (41.4, 52.1) | 31.9 | (30.9, 32.9) |
| Prevents cancer of the throat* | 39.0 | (34.0, 44.0) | 26.3 | (25.4, 27.3) |
| Reasons for not receiving vaccination | ||||
| Lack of provider’s recommendation (HPVa) | 24.2 | (18.9, 29.4) | 19.6 | (18.7, 20.6) |
| Lack of knowledge about HPVa * | 23.6 | (17.6, 29.6) | 14.9 | (14.1, 15.8) |
| Lack of provider’s recommendation (Tdapa) | 44.1 | (27.8, 60.5) | 28.7 | (26.2, 31.2) |
| Not needed or necessary (Tdapa) * | 7.1 | (2.8, 11.4) | 13.6 | (11.9, 15.3) |
| Lack of provider’s recommendation (MenACWYa) | 33.9 | (27.0, 40.7) | 37.2 | (36.0, 38.5) |
| Not needed or necessary (MenACWYa) * | 7.2 | (3.9, 10.5) | 11.6 | (10.7, 12.5) |
a
HPV: human papillomavirus vaccine; Tdap: Tetanus, diphtheria, and acellular pertussis vaccine; MenACWY: quadrivalent meningococcal conjugate vaccine.
b
CI: Confidence interval.
*
Statistically significantly different at the α = 0.05 level.